Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M1 Kliniken AGHAM:M12 -1.75%91 5-Year Yield-on-Cost % is 7.11 as of Jul. 27, 2026, which is 160% above its 10-year median of 2.73. GuruFocus rates HAM:M12 with a GF Score™ of 91/100 and a GF Value™ of €15.68 (Fairly Valued). Among 69 Medical Distribution companies, M1 Kliniken AG ranks better than 82.61% on this metric.
M1 Kliniken AG's yield on cost for the quarter that ended in Dec. 2025 was 7.11.
The historical rank and industry rank for M1 Kliniken AG's 5-Year Yield-on-Cost % or its related term are showing as below:
HAM:M12'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.73 Med: 2.73 Max: 7.11
Current: 7.11
During the past 12 years, M1 Kliniken AG's highest Yield on Cost was 7.11. The lowest was 1.73. And the median was 2.73.
HAM:M12's 5-Year Yield-on-Cost % is ranked better than 82.61% of 69
companies
in the Medical Distribution industry
Industry Median: 3.09
vs HAM:M12: 7.11
M1 Kliniken AG (HAM:M12) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
M1 Kliniken AG 5-Year Yield-on-Cost % Related Terms
HAM:M12 vs MCK, COR, CAH: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, M1 Kliniken AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of M1 Kliniken AG is calculated as
M1 Kliniken AG (HAM:M12) has a 5-Year Yield-on-Cost % of 7.11 as of Jul. 27, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on M1 Kliniken AG and its competitors. This is 160% above median its historical median of 2.73. Over the past decade, M1 Kliniken AG's 5-Year Yield-on-Cost % has ranged from 1.73 to 7.11. According to the industry distribution chart, M1 Kliniken AG ranks #12 out of 69 companies in the Medical Distribution industry, placing it in the top 17.4%.
Is M1 Kliniken AG's 5-Year Yield-on-Cost % too high?
M1 Kliniken AG's current 5-Year Yield-on-Cost % of 7.11 is 160% above median its 10-year median of 2.73. Over the past 10 years, this metric has ranged from a low of 1.73 to a high of 7.11. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.09. M1 Kliniken AG's value of 7.11 is 130.1% above this industry median. Based on the distribution chart, M1 Kliniken AG ranks #12 out of 69 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, M1 Kliniken AG has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's 5-Year Yield-on-Cost % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #12 out of 69 companies for 5-Year Yield-on-Cost %. This places M1 Kliniken AG in the top 17% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 3.09. M1 Kliniken AG's value of 7.11 is 130.1% above this benchmark. Historically, M1 Kliniken AG's own 5-Year Yield-on-Cost % has ranged from 1.73 to 7.11 over the past decade. While the company's 10-year median is 2.73 vs. the industry median of 3.09, M1 Kliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.09, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M1 Kliniken AG's current 5-Year Yield-on-Cost % of 7.11 is 130.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on M1 Kliniken AG and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current 5-Year Yield-on-Cost % is 7.11, which is 160% above median its own 10-year median of 2.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
Based on GuruFocus' analysis, M1 Kliniken AG (HAM:M12) is currently considered Fairly Valued. The stock's GF Value™ is €15.68, compared to a current price of €16.88 — trading 7.7% above its estimated fair value. The current 5-Year Yield-on-Cost % is 7.11, which is 160% above median its 10-year median of 2.73 and 130.1% above the Medical Distribution industry median of 3.09. M1 Kliniken AG's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For M1 Kliniken AG (HAM:M12), the current 5-Year Yield-on-Cost % is 7.11 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (HAM:M12) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of €16.88 is trading 7.7% above its estimated GF Value™ of €15.68.
GuruFocus considers M1 Kliniken AG to be Fairly Valued.
Key valuation signals for HAM:M12:
5-Year Yield-on-Cost %: 7.11 (160% above median its 10-year median of 2.73)
GF Value™: €15.68 vs. price of €16.88 (7.7% above fair value)
Industry Position: 130.1% above the Medical Distribution median (#12 of 69)
No single metric tells the full story. See the HAM:M12 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
91GF Score
Get the complete analysis for HAM:M12
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:M12 has been successfully added to your 
